Pine Haven Investment Counsel, Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1899753 FAIRHAVEN, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$233,855

-$24,815 QoQ

Shares Held

1,851

-0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,827

of 2,266 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pine Haven Investment Counsel, Inc holds $11,878,503 across 7 Drug Manufacturers - General names. GILD ranks #6 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	17,973	$4,522,725
2	AMGN	Amgen Inc	6,341	$2,296,202
3	JNJ	Johnson & Johnson	8,955	$2,274,301
4	MRK	Merck & Co., Inc.	14,273	$1,834,080
5	LLY	ELI LILLY & Co	427	$512,156
6	GILD	Gilead Sciences, Inc. This page	1,851	$233,855
7	BMY	Bristol Myers Squibb Co	3,561	$205,184

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$233,855	1,851	-0.3%	Shares	Sole	2026-07-08
2026-03-31	$258,670	1,856	0.0%	Shares	Sole	2026-04-16
2025-12-31	$227,805	1,856	0.0%	Shares	Sole	2026-01-08
2025-09-30	$206,016	1,856	0.0%	Shares	Sole	2025-10-21
2025-06-30	$205,774	1,856	-11.9%	Shares	Sole	2025-07-15
2025-03-31	$235,977	2,106	-17.1%	Shares	Sole	2025-04-11
2023-12-31	$205,684	2,539	-8.1%	Shares	Sole	2024-01-22
2023-09-30	$207,134	2,764	0.0%	Shares	Sole	2023-11-06
2023-06-30	$213,021	2,764	-14.8%	Shares	Sole	2023-08-03
2023-03-31	$269,154	3,244	-7.2%	Shares	Sole	2023-05-02
2022-12-31	$299,959	3,494	-12.9%	Shares	Sole	2023-01-18
2022-09-30	$247,438	4,011	-0.5%	Shares	Sole	2022-11-08
2022-06-30	$249,279	4,033	+0.0%	Shares	Sole	2022-08-10
2022-03-31	$239,702	4,032	-5.1%	Shares	Sole	2022-05-09
2021-12-31	$308,592	4,250	—	Shares	Sole	2022-02-09
No filing history on record for this holder in this stock.